• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不依赖血小板生成素的巨核细胞生成

TPO-independent megakaryocytopoiesis.

作者信息

Zheng Cuiling, Yang Renchi, Han Zhongchao, Zhou Bin, Liang Lu, Lu Min

机构信息

State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, PR China.

出版信息

Crit Rev Oncol Hematol. 2008 Mar;65(3):212-22. doi: 10.1016/j.critrevonc.2007.11.003.

DOI:10.1016/j.critrevonc.2007.11.003
PMID:18093840
Abstract

Megakaryocytopoiesis is a continuous developmental process of platelet production. In this process, a complex network of hemopoietic growth factors are involved, among which TPO (thrombopoietin) is the most thoroughly investigated regulator of MKs (megakaryocytes). In addition to TPO, other regulators also have non-negligible effects on megakaryocytopoiesis. The majority of their effects are independent of TPO signaling. To date, TPO-independent megakaryocytopoiesis forms a regulatory system that includes four signals and (an) unknown signaling pathway(s). These four pathways are the gp 130 (glycoprotein 130)-dependent signaling pathway, the Notch pathway, NMDA (N-methyl-d-aspartate) receptor-mediated signaling, and the SDF-1 (stromal cell-derived factor-1)/FGF-4 (fibroblast growth factor-4) paradigm. Understanding of the TPO-independent regulatory system is important because the system may offer additional opportunities to understand the developmental process and the mechanisms of disorders characterized by abnormal MK and platelet production, such as thrombocytopenia and thrombocythemia, and to advance the development of therapeutics.

摘要

巨核细胞生成是血小板产生的一个持续的发育过程。在这个过程中,涉及一个复杂的造血生长因子网络,其中血小板生成素(TPO)是对巨核细胞(MKs)研究最深入的调节因子。除了TPO,其他调节因子对巨核细胞生成也有不可忽视的作用。它们的大多数作用独立于TPO信号传导。迄今为止,不依赖TPO的巨核细胞生成形成了一个包括四个信号和未知信号通路的调节系统。这四条通路是依赖糖蛋白130(gp 130)的信号通路、Notch通路、N-甲基-D-天冬氨酸(NMDA)受体介导的信号通路以及基质细胞衍生因子-1(SDF-1)/成纤维细胞生长因子-4(FGF-4)模式。对不依赖TPO的调节系统的了解很重要,因为该系统可能为理解发育过程以及以MK和血小板生成异常为特征的疾病(如血小板减少症和血小板增多症)机制提供更多机会,并推动治疗方法发展。

相似文献

1
TPO-independent megakaryocytopoiesis.不依赖血小板生成素的巨核细胞生成
Crit Rev Oncol Hematol. 2008 Mar;65(3):212-22. doi: 10.1016/j.critrevonc.2007.11.003.
2
[Megakaryocyte development and platelet production in normal and disease states].[正常及疾病状态下的巨核细胞发育与血小板生成]
Harefuah. 2010 May;149(5):291-7, 336.
3
Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.血小板生成素模拟物在免疫性血小板减少性紫癜治疗中的应用
Semin Hematol. 2007 Oct;44(4 Suppl 5):S35-45. doi: 10.1053/j.seminhematol.2007.11.005.
4
Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.巨核细胞的生长和成熟由衔接蛋白Lnk/Sh2b3通过细胞因子介导信号和整合素介导信号之间的相互作用来调控。
Exp Hematol. 2008 Jul;36(7):897-906. doi: 10.1016/j.exphem.2008.02.004. Epub 2008 May 5.
5
AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.AKR-501(YM477)与血小板生成素联合使用可增强人类巨核细胞生成。
Exp Hematol. 2008 Oct;36(10):1337-42. doi: 10.1016/j.exphem.2008.04.020. Epub 2008 Jul 10.
6
Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers.巨核细胞生成与血小板生成:细胞因子和谱系表面标志物的最新进展
Methods Mol Biol. 2012;788:291-303. doi: 10.1007/978-1-61779-307-3_20.
7
Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia.
Stem Cells. 2005 Aug;23(7):975-82. doi: 10.1634/stemcells.2004-0227.
8
Megakaryocyte development and platelet production.巨核细胞发育与血小板生成。
Br J Haematol. 2006 Sep;134(5):453-66. doi: 10.1111/j.1365-2141.2006.06215.x.
9
Macrophage derived signalling regulates negatively the megakaryocyte compartment.巨噬细胞衍生的信号传导对巨核细胞区室起负调控作用。
Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL667-75.
10
NMDA receptor-mediated regulation of human megakaryocytopoiesis.N-甲基-D-天冬氨酸受体介导的人类巨核细胞生成调节
Blood. 2003 Aug 15;102(4):1254-9. doi: 10.1182/blood-2002-11-3553. Epub 2003 Mar 20.

引用本文的文献

1
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.通过 5-HT1A 受体激活 SRC/MAPK 信号通路有助于维拉唑酮改善血小板减少症的作用。
Elife. 2024 Apr 4;13:RP94765. doi: 10.7554/eLife.94765.
2
Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.针对巨核细胞生成的新型诱导剂 DMAG 的发现,采用一种非依赖于血小板生成素的策略,用于治疗血小板减少症。
Haematologica. 2023 May 1;108(5):1394-1411. doi: 10.3324/haematol.2022.282209.
3
A Novel Antithrombocytopenia Agent, , Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.
一种新型抗血小板药物,通过 PI3K/AKT、MEK/ERK 和 JAK2/STAT3 信号通路促进巨核细胞生成和血小板生成。
Int J Mol Sci. 2022 Nov 14;23(22):14060. doi: 10.3390/ijms232214060.
4
A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia.增殖诱导配体和B细胞活化因子在原发性血小板增多症患者中上调。
J Clin Med. 2022 Aug 9;11(16):4663. doi: 10.3390/jcm11164663.
5
Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.抑制原肌球蛋白受体激酶 A 信号通路可负向调节巨核细胞生成并诱导血小板生成。
Sci Rep. 2019 Feb 26;9(1):2781. doi: 10.1038/s41598-019-39385-x.
6
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis.NF-κB 在炎症与血栓形成中的细胞类型特异性作用。
Front Immunol. 2019 Feb 4;10:85. doi: 10.3389/fimmu.2019.00085. eCollection 2019.
7
Arachidonic acid and Docosahexanoic acid enhance platelet formation from human apheresis-derived CD34 cells.花生四烯酸和二十二碳六烯酸可增强源自人单采血液成分的CD34细胞的血小板生成。
Cell Cycle. 2017 May 19;16(10):979-990. doi: 10.1080/15384101.2017.1312233. Epub 2017 Apr 7.
8
Identification of a potent small molecule capable of regulating polyploidization, megakaryocyte maturation, and platelet production.鉴定一种能够调节多倍体化、巨核细胞成熟和血小板生成的强效小分子。
J Hematol Oncol. 2016 Dec 8;9(1):136. doi: 10.1186/s13045-016-0358-y.
9
Platelet Interaction with Innate Immune Cells.血小板与天然免疫细胞的相互作用。
Transfus Med Hemother. 2016 Mar;43(2):78-88. doi: 10.1159/000444807. Epub 2016 Mar 9.
10
Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.了解巨核细胞产生血小板的过程:对体外衍生血小板的意义。
Blood. 2016 Mar 10;127(10):1227-33. doi: 10.1182/blood-2015-08-607929. Epub 2016 Jan 19.